Sign in

CIK 0000949858

  • Non-accelerated filer
  • Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Tickers
ACHV QUIT
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
954343413
Phone
+1 425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC

Securities

  • ACHV Common stock Nasdaq
  • QUIT Common Shares Nasdaq
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Grant or award Chief Scientific Officer acquired 16,971,560 shares (grant or award)
  4. 4 Grant or award President & CEO acquired 23,335,897 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 4 Shares withheld for taxes President and CEO gave up 4,472 shares (to pay taxes)
  10. 4 Shares withheld for taxes EVP, CMO gave up 1,633 shares (to pay taxes)
  11. 4 Shares withheld for taxes EVP, CMO gave up 3,369 shares (to pay taxes)
  12. 4 Shares withheld for taxes CFO gave up 1,021 shares (to pay taxes)
  13. 4 Shares withheld for taxes President and CEO gave up 9,690 shares (to pay taxes)
  14. 4 Open-market sale CFO sold 1,380 shares at $0.57 ($787)
  15. 4 Open-market sale EVP, CMO sold 1,437 shares at $1.03 ($1,473)
  16. 4 Open-market sale President and CEO sold 4,856 shares at $1.03 ($4,979)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 12 of 24 · 465 filings